AARON SAHLE: Open Payments
NPI 1285249540 · SPRING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 28 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $347 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $202 |
| Novo Nordisk Inc | 4 | $81 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| Corcept Therapeutics | 2 | $37 |
| Lilly USA, LLC | 2 | $32 |
| GlaxoSmithKline, LLC. | 1 | $27 |
| Dexcom, Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Alkermes, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: VRAYLAR, ABILIFY ASIMTUFII, Korlym, Wegovy, Rybelsus, SHINGRIX, Dexcom G6 Transmitter, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
